The Drug Science Podcast

Being diagnosed with a terminal disease can provoke extreme psychological distress, depression and anxiety. Current pharmacological treatments take a long time to exert an effect, if any. Psychedelics offer a new, fast-acting treatment for palliative patients.

Show Notes

If you were told you had months, weeks or even days left to live...would you care what the law said about consuming psychoactive substances? This week’s episode features Spencer Hawkswell the CEO of TheraPsil - a non-profit coalition dedicated to helping Canadians in medical need access legal, psilocybin-assisted psychotherapy to treat end-of-life distress. 

Spencer believes that responsible drug policy requires effective organization and leadership and is dedicated to bringing together the experts and advocates, to facilitate change that results in increased access to compassionate care, harm reduction, and treatment options for those in need.

Tune in to this week’s episode to hear how the Land of Maple Leaf implements its patient-centred approach in healthcare. What happened in the UK? Are there lessons to be learnt from Canada? 

 

Psilocybin

Cannabis

Trigeminal neuralgia 

Patty Hajdu

Jean-Yves Duclos

Health Canada

Fentanyl 

Clonazepam 

Section 56 Exemption 

Roland R. Griffiths

Mathew W. Johnson

Robin Carhart-Harris

Anthony P. Bossis

Ketamine

Holotropic breathwork

Cluster headache

ADHD

Acid (LSD)

Medical assistance in dying

Letter to Minister Duclos

Re: Proposed Regulations for Medical Access to Psilocybin

★ Support this podcast ★

What is The Drug Science Podcast?

Professor David Nutt has spent a career making the argument for a rational, evidence-based approach to drug policy and drug use. The scientific evidence still challenges perceived wisdom on drugs and for that reason can appear to be contentious. In this podcast, the Professor explores the actual harms and potential benefits of various drugs, challenging myths surrounding classification and legislation, and exploring the societal impact of poorly informed drug policy. Using evidence in public policy should not be controversial. A podcast for anyone interested in understanding the scientific truth about drugs, free from political or moral concern.